BCL2 and cancer: For BCL2, whose overexpression is linked to a large variety of cancers [65], deletion of a G4-forming region immediately before the TSS increases promoter activity [66], and when this region is placed upstream from a reported gene, G4-disruptive mutations increase expression while G4-binding ligands reduce it [31].